Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)
<i>Background:</i> Ocrelizumab is an effective medication for multiple sclerosis. However, infusion-related reactions (IRRs) are a concern for patients and may lead to discontinuation of ocrelizumab. To minimize IRRs, pre-medications are administered. However, from our experience, these medications,...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2024-04-01
|
| Schriftenreihe: | Medicina |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1648-9144/60/4/659 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|